Stock ONCO ONCONETIX, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Onconetix, Inc.

Equities

ONCO

US09610B1089

End-of-day quote Nasdaq
Other stock markets
 06:00:00 2024-05-27 pm EDT 		5-day change 1st Jan Change
0.1639 USD -9.90% Intraday chart for Onconetix, Inc. -9.90% -17.22%
May. 20 Onconetix, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 11 Onconetix, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Oncopeptides AB - First patients in Spain to be treated with Pepaxti
AQ
Onconetix, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Immunovia Publishes Interim Report for January-March 2024
AQ
Onconetix, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Onconetix Announces Appointment of Seasoned Biotech Executives Dr. Ajit Singh and Dr. Thomas Meier to Its Board of Directors
AQ
Onconetix, Inc. Announces Appointment of Ajit Singh to its Board of Directors
CI
Onconetix, Inc. Appoints Thomas Meier to the Board of Directors
CI
Nasdaq Stocks Under $1 to Watch Now! VTAK, IVP, ONCO, AKTS, RDHL
AQ
Wall Street Set to Open Marginally Lower Friday; December Inflation Data Lower Than Forecast
MT
US Futures Nudge Lower in Friday's Premarket Ahead of Fed Inflation Data
MT
Onconetix, Inc. announced that it has received $5 million in funding
CI
Onconetix, Inc. Announces Chief Executive Officer Changes
CI
Onconetix, Inc. Announces Executive Changes
CI
Onconetix, Inc. Announces Resignation of Erin Henderson as Chief Business Officer
CI
Onconetix, Inc.(NasdaqCM:ONCO) added to NASDAQ Composite Index
CI
Onconetix, Inc. Announces Executive Appointments
CI
Onconetix, Inc.(NasdaqCM:ONCO) dropped from NASDAQ Composite Index
CI
Blue Water Biotech, Inc. acquired ProteoMediX AG for $51.9 million.
CI
Onconetix™ Chief Executive Officer Dr. Neil J. Campbell Issues Letter to Shareholders
AQ
Blue Water Biotech Acquires Proteomedix as Part of Transformation to Commercial Stage Oncology Company; Announces Name Change to Onconetix™
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ONCO Stock
  4. News Onconetix, Inc.